These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 333568)

  • 21. Some observations on patient compliance in an antidepressive trial.
    Witts DJ; Mulgirigama D; Turner P; Pare CM
    Postgrad Med J; 1977; 53 Suppl 4():136-8. PubMed ID: 341102
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative study of maprotiline (Ludiomil) and viloxazine in the management of depressed patients in general practice.
    Lomas DM
    J Int Med Res; 1977; 5 Suppl 4():39-50. PubMed ID: 338401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Combined chlorimipramine and maprotiline therapy in therapy-resistant depressions].
    Soucek K
    Act Nerv Super (Praha); 1982 May; 24(2):88-9. PubMed ID: 7102229
    [No Abstract]   [Full Text] [Related]  

  • 24. A double-blind comparative clinical trial with maprotiline (Ludiomil) and imipramine in newly-admitted depressed patients.
    Lehmann HE; Pecknold JC; Ban TA; Orbach L
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):463-8. PubMed ID: 816604
    [No Abstract]   [Full Text] [Related]  

  • 25. A double-blind randomized study of clomipramine versus maprotiline in patients with idiopathic pain syndromes.
    Eberhard G; von Knorring L; Nilsson HL; Sundequist U; Björling G; Linder H; Svärd KO; Tysk L
    Neuropsychobiology; 1988; 19(1):25-34. PubMed ID: 3054623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proceedings: Systematic clinical studies with clomipramine in depressed psychiatric patients--IV. A summary report.
    Lehmann HE; Ban TA; Pecknold JC
    Psychopharmacol Bull; 1976 Jan; 12(1):27-9. PubMed ID: 1108080
    [No Abstract]   [Full Text] [Related]  

  • 27. [Double blind study on maprotiline, an example of a multidimensional psychopharmacologic experiment (author's transl)].
    Bergener M; Hesse C; Hummel F; Husser J; Kern U; Neller K; Reiners I
    Pharmakopsychiatr Neuropsychopharmakol; 1978 Mar; 11(2):63-7. PubMed ID: 347465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of maprotiline and amitriptyline in the treatment of depression in general practice.
    Silverstone JT; Carne HJ; Dell A; Franklin CJ; Singer R; Swirsky SN; Forrest WA
    Practitioner; 1977 Feb; 218(1304):279-82. PubMed ID: 320594
    [No Abstract]   [Full Text] [Related]  

  • 29. Urinary amine metabolites in depression: a combined biochemical and general practice study: I. Clinical aspects.
    Parrack S; Ridges AP
    J Int Med Res; 1980; 8 Suppl 3():27-36. PubMed ID: 7202816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe depression treatment: experience using maprotiline (Ludiomil) in combination with clomipramine (Anafranil).
    Ovuga E
    East Afr Med J; 1985 Feb; 62(2):79-81. PubMed ID: 4042927
    [No Abstract]   [Full Text] [Related]  

  • 31. Proceedings: Clinical experience with sydnocarb in neuroses and psychoses.
    Zapletálek M; Hubsch T; Kindernayová H
    Act Nerv Super (Praha); 1975; 17(4):235-6. PubMed ID: 3934
    [No Abstract]   [Full Text] [Related]  

  • 32. Biological predictors of success of antidepressant drug therapy.
    Fähndrich E
    Psychiatr Dev; 1987; 5(2):151-71. PubMed ID: 3628243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
    Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
    J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Double-blind study of oxaprotiline versus clomipramine in the treatment of depressive inpatients.
    Wolfersdorf M; Binz U; Wendt G; Metzger R; Hole G
    Neuropsychobiology; 1987; 17(1-2):41-8. PubMed ID: 3306439
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
    Singh AN; Saxena B; Gent M; Nelson HL
    Curr Ther Res Clin Exp; 1976 Apr; 19(4):451-62. PubMed ID: 816603
    [No Abstract]   [Full Text] [Related]  

  • 36. A clinical trial of a 50 mg formulation of clomipramine (Anafranil) with steady-state plasma level measurements.
    Gringras M; Luscombe DK; Jones RB; Beaumont G; Seldrup J; John V
    J Int Med Res; 1977; 5(1 Suppl):119-24. PubMed ID: 863081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and electroencephalographic study of a new antidepressive agent, mono-methyl-amino-propyl-dibenzo-bicyclo-octadine hydrochloride (Ciba 34, 276 Ba)].
    Deniker P; Lôo H; Verdeaux G; Oughourlian JM
    Encephale; 1975; 1(3):265-78. PubMed ID: 1227822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluoxetine 40 mg vs maprotiline 75 mg in the treatment of out-patients with depressive disorders.
    Poelinger W; Haber H
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():47-50. PubMed ID: 2644340
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison of the therapeutic effects of lofepramine and maprotiline in depression].
    Finke G; Wegener G
    MMW Munch Med Wochenschr; 1982 Mar; 124(12):301-3. PubMed ID: 6804813
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of antidepressants on the secretion of pituitary hormones in healthy subjects, neurotic depressive patients and endogenous depressive patients (author's transl)].
    Laakmann G
    Nervenarzt; 1980; 51(12):725-32. PubMed ID: 7207684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.